10 junio 2015
Using the intestinal hormone GLP-1 in obesity treatment prevents the loss of bone mass otherwise frequently associated with major weight loss. According to the researchers behind the study, the results may have a significant bearing on future obesity treatment.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/phdZS4PE_Vs/150610131636.htm
